Creo Medical Appoints Deutsche Numis as Nominated Adviser and Broker
Why we think this is neutral
This RNS announcement is a routine regulatory update regarding the appointment of a new Nominated Adviser and sole Broker for Creo Medical Group PLC. It does not contain any information about the company's financial performance or operations, and is therefore unlikely to have a material impact on the business. The announcement is informational in nature and does not provide any significant positive or negative insights.
Key Points
- Creo Medical Group PLC appoints Deutsche Numis as Nominated Adviser and sole Broker
- The appointment is effective immediately
Summary
The medical device company has appointed Deutsche Numis as its new Nominated Adviser and sole Broker.
Creo Medical Group plc (AIM: CREO), a medical device company focused on minimally invasive surgical endoscopy, has announced the appointment of Deutsche Numis as the Company's Nominated Adviser, sole Broker and Financial Adviser with immediate effect.
GENERAL UPDATE